13 completed. 4 Phase 1, 3 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 3 | Completed 3 |
| Not applicable | 1 | Completed 1 |
Follow Regional Neuroblastoma: new trials by email Literature Review of Regional Neuroblastoma trials Research Report on Regional Neuroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin 3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, Busulfan - Ganglioneuroblastoma, Localized Resectable Neuroblastoma | Phase 1 | Completed | Children's Oncology Group | 99 | 2011-12-21 | 2026-01-23 |
| Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma Cytology Specimen Collection Procedure, Pharmacological Study - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Completed | National Cancer Institute (NCI) | 12 | 2011-05-26 | 2019-10-01 | |
| Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma Isotretinoin, Laboratory Biomarker Analysis, Pharmacological Study - Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma | Phase 1 | Completed | National Cancer Institute (NCI) | 29 | 2010-12-01 | 2015-11-24 |
| Study of Specimens From Young Patients With Neuroblastoma laboratory biomarker analysis - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Completed | Children's Oncology Group | 350 | 2008-12-01 | 2016-05-18 | |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Autologous Hematopoietic Stem Cell Transplantation, Carboplatin, Cisplatin - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Completed | Children's Oncology Group | 665 | 2007-11-05 | 2022-04-28 |
| Study of DNA in Blood Samples From Patients With Neuroblastoma laboratory biomarker analysis, polymerase chain reaction, polyacrylamide gel electrophoresis - Disseminated Neuroblastoma, Localized Resectable Neuroblastoma | Completed | Children's Oncology Group | 329 | 2007-06-01 | 2016-05-18 | |
| Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions Laboratory Biomarker Analysis - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Completed | Children's Oncology Group | 9350 | 2006-12-11 | 2018-08-07 | |
| High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors etoposide, cyclophosphamide, carmustine - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Not applicable | Completed | Roswell Park Cancer Institute | 174 | 2006-06-29 | 2021-04-22 |
| Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Clinical Observation, Cyclophosphamide, Laboratory Biomarker Analysis - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Completed | Children's Oncology Group | 53 | 2004-03-15 | 2023-04-18 |
| R(+)XK469 in Treating Patients With Advanced Neuroblastoma R(+)XK469 - Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 1 | Completed | National Cancer Institute (NCI) | 85 | 2001-12-01 | 2013-12-16 |
| Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Aldesleukin, Dinutuximab, Isotretinoin - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Completed | National Cancer Institute (NCI) | 1449 | 2001-10-26 | 2026-03-05 |
| Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma monoclonal antibody Ch14.18, isotretinoin, aldesleukin - Disseminated Neuroblastoma, Recurrent Neuroblastoma | Phase 1 | Completed | National Cancer Institute (NCI) | 6 | 2001-01-01 | 2013-01-16 |
| Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Ganglioneuroblastoma, Localized Resectable Neuroblastoma | Completed | Children's Oncology Group | 10000 | 2000-11-06 | 2026-07-09 |
Neuroblastoma (12) · Ganglioneuroblastoma (2) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Hodgkin Disease (1) · Immunoglobulin Light-chain Amyloidosis (1) · Intraocular Lymphoma (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1)
Neoplasms (12) · Neoplasms by Histologic Type (12) · Neoplasms, Germ Cell and Embryonal (12) · Neoplasms, Glandular and Epithelial (12) · Neoplasms, Nerve Tissue (12) · Neoplasms, Neuroepithelial (12) · Neuroectodermal Tumors (12) · Neuroectodermal Tumors, Primitive (12) · Neuroectodermal Tumors, Primitive, Peripheral (11) · Pathological Conditions, Signs and Symptoms (2) · Amyloidosis (1) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Chemically-Induced Disorders (1) · Chronic Disease (1)
Isotretinoin (5) · Cyclophosphamide (4) · Melphalan (3) · 1,2-diaminocyclohexaneplatinum II citrate (2) · Busulfan (2) · Carboplatin (2) · Cisplatin (2) · Doxorubicin (2) · Etoposide (2) · Platinum (2) · Thiotepa (2) · Topotecan (2) · Vincristine (2) · aldesleukin (2) · dinutuximab (2)
Children's Oncology Group (7) · National Cancer Institute (NCI) (5) · Roswell Park Cancer Institute (1)
United States (13) · Canada (5) · Australia (4) · New Zealand (3) · Puerto Rico (3) · Switzerland (2) · Netherlands (1) · Saudi Arabia (1)
Michael Hogarty, MD (2) · Alice L Yu (1) · Andrew Gilman (1) · Brian D Weiss (1) · Frank M Balis (1) · John Maris (1) · Julie Park (1) · Julie R Park (1) · Michael Hogarty (1) · Pedro A De Alarcon (1) · Philip McCarthy (1) · Susan Cohn (1)
PMID 20879881, PMID 29376112, PMID 31454045, PMID 32530765, PMID 34028986, PMID 35839426, PMID 37883734, PMID 38815188, PMID 40036726, PMID 42487567
U10CA098543 (5), U10CA180886 (5), P01CA081403 (1), P30CA016056 (1), P30CA016520 (1), U01CA069852 (1), U10CA013539 (1), U10CA030969 (1), UG1CA189958 (1)